HomeCompareBKEAY vs PFE

BKEAY vs PFE: Dividend Comparison 2026

BKEAY yields 3.74% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BKEAY wins by $589.6K in total portfolio value
10 years
BKEAY
BKEAY
● Live price
3.74%
Share price
$1.67
Annual div
$0.06
5Y div CAGR
54.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$639.2K
Annual income
$384,747.07
Full BKEAY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BKEAY vs PFE

📍 BKEAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBKEAYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BKEAY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BKEAY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BKEAY
Annual income on $10K today (after 15% tax)
$317.94/yr
After 10yr DRIP, annual income (after tax)
$327,035.01/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, BKEAY beats the other by $304,715.11/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BKEAY + PFE for your $10,000?

BKEAY: 50%PFE: 50%
100% PFE50/50100% BKEAY
Portfolio after 10yr
$344.4K
Annual income
$205,502.89/yr
Blended yield
59.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BKEAY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
0.2
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BKEAY buys
0
PFE buys
0
No recent congressional trades found for BKEAY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBKEAYPFE
Forward yield3.74%6.13%
Annual dividend / share$0.06$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR54.9%13.2%
Portfolio after 10y$639.2K$49.6K
Annual income after 10y$384,747.07$26,258.71
Total dividends collected$591.6K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldHold

Year-by-year: BKEAY vs PFE ($10,000, DRIP)

YearBKEAY PortfolioBKEAY Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,279$579.40$9,153$693.39+$2.1KBKEAY
2$13,015$946.09$8,593$849.25+$4.4KBKEAY
3$15,506$1,580.37$8,336$1,066.78+$7.2KBKEAY
4$19,318$2,725.80$8,437$1,384.80+$10.9KBKEAY
5$25,586$4,915.93$9,013$1,875.40+$16.6KBKEAY
6$36,803$9,425.78$10,306$2,680.72+$26.5KBKEAY
7$59,006$19,627.46$12,820$4,101.38+$46.2KBKEAY
8$108,693$45,556.55$17,673$6,826.70+$91.0KBKEAY
9$237,787$121,485.02$27,543$12,591.86+$210.2KBKEAY
10$639,179$384,747.07$49,560$26,258.71+$589.6KBKEAY

BKEAY vs PFE: Complete Analysis 2026

BKEAYStock

The Bank of East Asia, Limited, together with its subsidiaries, provides various banking and related financial services. Its personal banking services include corporate, individual, savings, current, time deposit, and supreme accounts; and fixed and call deposits, foreign currency deposits, MAS services, and auto-payroll products, as well as safe deposit boxes and remittance services. The company also provides corporate banking services, such as SME loans and financing guarantee schemes; corporate and commercial financing products, including syndicated and construction loans, acquisition and structured financing, working capital financing, share financing and IPO-related loans, and commercial mortgages; trade finance services and expert trade solutions; factoring services; import and export trade finance; guarantee services; eTradeConnect that allows buyers and sellers to connect, transact, share information, and submit applications for financing through a single platform; cash management services; corporate wealth management products; foreign exchange and treasury products; trade settlement and financing services; onshore and offshore loans; and marine cargo, property, trade credit, employee compensation, pet, medical, life, savings, and endowment insurance plans. In addition, it offers private banking services comprising investment advisory services; investment solutions, such as unit trusts, linked deposits, currency trading and management, global equities and bonds investments, structured products, and options and derivatives; portfolio management services; securities and futures broking services; cyber banking, credit cards, and ATM; and various international services. The company operates 150 outlets in Hong Kong, rest of Greater China, Southeast Asia, the United Kingdom, and the United States. The Bank of East Asia, Limited was incorporated in 1918 and is headquartered in Central, Hong Kong.

Full BKEAY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BKEAY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BKEAY vs SCHDBKEAY vs JEPIBKEAY vs OBKEAY vs KOBKEAY vs MAINBKEAY vs JNJBKEAY vs MRKBKEAY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.